Investing

Top Analyst Upgrades and Downgrades: Agilent, Bausch Health, Bluebird Bio, Cree, Facebook, Fortive, Oshkosh, Palantir and More

Nexa Resources S.A. (NYSE: NEXA) was downgraded at Citigroup from Buy to Neutral with an $11 price target. The consensus target is $10.12, and the shares were last seen at $10.44 on Tuesday.

Oshkosh Corp. (NYSE: OSK) was upgraded to Buy from Hold at Jefferies, which also raised the price target to $125. The consensus target is $107.40. The stock closed on Tuesday at $99.03.

Palantir Technologies Inc. (NYSE: PLTR) was upgraded to Buy from Neutral at Goldman Sachs, which raised its price target to $34. William Blair downgraded it to Underperform from Market Perform. The consensus target is $19.83. The stock was nailed on Tuesday, closing down almost 13% at $27.84, after posting disappointing quarterly results. The shares bounced back some, almost 2%, in the premarket.

Regal-Beloit Corp. (NYSE: RBC) was raised from Sector Weight to Overweight with a $155 target at Keybanc Capital Markets. That posted consensus target is $136.29. The stock closed Tuesday at $132.95, up 3% on the day.

Rexnord Corp. (NYSE: RXN) was raised at Keybanc Capital Markets from Sector Weight to Overweight with a $60 price objective. The consensus objective is just $44.78. Tuesday’s closing price was $45.10 a share, following almost a 9% gain after the company posted a profit well above analyst estimates.

USA Compression Partners L.P. (NYSE: USAC) was downgraded from Outperform to Sector Perform with a $16 price target at RBC Capital Markets. The consensus target is $15, and the last trade for Tuesday came in at $15.03 per share.


Jefferies sees the potential for the United States economy to experience the best growth in 40 years. Five of the firm’s top cyclical stock picks offer solid value and big upside potential, and the companies are among the leaders in their specific sectors.

Five notable health care laggard stocks appear to have plenty of upside potential. Most of them are dividend payers too.

Tuesday’s early top analyst upgrades and downgrades included American Express, BlackBerry, BP, CrowdStrike, Noble Midstream, Waste Management and Zscaler. Analyst calls seen later in the day were on Alphabet, Constellation Brands, Mattel and more.